lobenzarit has been researched along with Acquired Autoimmune Hemolytic Anemia in 1 studies
lobenzarit: prevents autoimmune kidney disease in hybrid mice; RN given refers to parent cpd
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andou, S | 1 |
| Fujii, S | 1 |
| Harada, Y | 1 |
| Ooi, J | 1 |
| Nomiyama, J | 1 |
| Mori, K | 1 |
| Ookubo, M | 1 |
| Azuno, Y | 1 |
| Fujii, Y | 1 |
| Kaku, K | 1 |
1 other study available for lobenzarit and Acquired Autoimmune Hemolytic Anemia
| Article | Year |
|---|---|
Alpha-methyldopa-type autoimmune hemolytic anemia caused by lobenzarit disodium of a mefenamic acid derivative and immunomodulator.
Topics: Anemia, Hemolytic, Autoimmune; Humans; Immunosuppressive Agents; Male; Methyldopa; Middle Aged; orth | 1994 |